Search PubMed⌕ Search

Biomedical subjects

L Mojonnier

Publications and source records attributed to L Mojonnier.

13 recordsLinked to original sources
PubMed1983

Nervous tension and serum cholesterol: findings from the Chicago Coronary Prevention Evaluation Program.

Of 519 coronary-prone middle-aged men participating in the Chicago Coronary Prevention Evaluation Program, 416 reported their self-perceived state as one of no tension or tension at various periodic visits over years in the Program. Group mean serum cholesterol was significantly higher by about 4 mg/dl with tension vs. no tension (slight, moderate, or marked). This relationship was independent of weight change, intercurrent infection, use of medication, and month of year.

Adult↗
PubMed1982

Smoking cessation in the Chicago Coronary Prevention Evaluation Program.

Quit-rates for cigarette smokers in a lifestyle intervention program aimed at reducing coronary risk were 24 percent for all participants and 34 percent for non-dropouts. Recidivism remained very low during participation in the program. Half of the smokers who quit did so after being in the program more than two years. These data suggest that while engaging in an effort to make other changes in lifestyle, many smokers can be helped to quit. Sustained antismoking efforts in the clinical practice of medicine can be expected to share these same positive aspects. While mass public health programs to eliminate smoking and prevent young people from taking up the habit are being developed, health practitioners can make a significant contribution by including vigorous efforts at smoking cessation as part of routine practice.

Adult↗
PubMed1980

Fat-modified menu's ongoing success noted.

In 1972, a hospital food service introduced a fat-modified selective cycle menu program for its patients, staff members, and visitors. Goals and implementation are discussed.

Attitude of Health Personnel↗
PubMed1980

Nutrition in the Multiple Risk Factor Intervention Trial (MRFIT).

The Multiple Risk Factor Intervention Trial (MRFIT) is a clinical trial to determine whether primary prevention of coronary heart disease (CHD) is achievable. The main objective is to learn whether a special intervention program for men at increased risk of death from CHD can result in a significant reduction in mortality from this disease. For this investigation, 12,866 men, ages thirty-five to fifty-seven years, have been enrolled, after having been identified at increased risk because of a combination of risk factors: Elevated serum cholesterol, elevated diastolic blood pressure, and cigarette smoking. MRFIT provides an excellent opportunity for nutritionists to work closely with physicians, behavioral scientists, nurses, and other scientists in a program to change food habits, reduce blood pressure, and achieve cessation of smoking.

Cholesterol↗
PubMed1977

Plasma glucose levels: long-term effect of diet in the Chicago Coronary Prevention Evaluation Program.

In 150 middle-aged men prone to coronary disease, long-term data based on the Chicago Coronary Prevention Evaluation Program's diet showed that there was a favorable effect on fasting glycemia level and glucose tolerance. This diet for reducing obesity and hypercholesterolemia was low in cholesterol and saturated fat and moderate in polyunsaturated and total fat, with replacement of some fat by carbohydrate. At 2 years, decreased weight and serum cholesterol values of normoglycemic men were accompanied by a modest but significant fall in fasting and postload glycemia; at 4 years. fasting glycemia levels remained slightly below baseline. For men with suspect fasting hyperglycemia at baseline, sustained fall in weight and serum cholesterol value was associated with sizeable long-term reductions in fasting glycemia and improvement of glucose tolerance. Decrease in plasma glucose was significantly related to decrease in weight. No evidence of impairment of glucose tolerance with years-long consumption of this diet was recorded.

Blood Glucose↗